China Dasheng Biotechnology Company

07/25/2024 | Press release | Distributed by Public on 07/24/2024 19:27

CDBT acknowledges Convertible Note cancellation, Non-Dilution and Registration Rights agreements

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.